Visão geral da empresa
Zhongchao Inc. operates within the healthcare sector, specifically focusing on the Health Information Services industry by providing specialized healthcare information, education, and training services to professionals through its MDMOOC brand platform in the People's Republic of China. The company's operational structure is divided into two primary segments, delivering MDMOOC services and engaging in the sales of patented drugs, while also offering patient management services. In terms of corporate scale, Zhongchao Inc. maintains a market capitalization of $7.42M and reported annual revenue of $11.37M over the trailing twelve months, though specific employee count data is not publicly disclosed. These valuation and revenue figures indicate that the company occupies a niche position within the broader healthcare market, reflecting a small-cap status that is characterized by lower total market value and revenue relative to large-cap peers in the Health Information Services industry.
Saúde financeira
The company reported revenue of $11.37M and net income of -$6,310,153, with an EBITDA of -$5,901,042, revealing a significant gap between top-line revenue and bottom-line earnings that indicates substantial operational expenses or losses relative to sales volume. Free cash flow stands at -$1,112,632, suggesting that the company is currently consuming cash rather than generating it, which limits its immediate financial flexibility for capital expenditures or unexpected liabilities without external financing. Margin analysis shows a gross margin of 45.0%, which suggests a healthy pricing power or efficient production costs for goods sold, contrasting sharply with an operating margin of -92.0% and a profit margin of -55.5% that highlight severe inefficiencies in operating expenses or high fixed costs eroding profitability. The balance sheet holds $13.92M in cash against $26,083 in debt, resulting in a debt-to-equity ratio of 0.12, which indicates a conservative capital structure with minimal leverage despite the current net loss position. Liquidity is robust, evidenced by a current ratio of 11.11, implying that the company holds significantly more current assets than current liabilities and is well-positioned to meet short-term obligations. Return on Equity is -24.9% and Return on Assets is -15.5%, metrics that reveal that management has not yet achieved positive capital efficiency, as the company is generating negative returns on the equity invested by shareholders and the assets it controls.
Avaliação de valorização
Trailing P/E and forward P/E ratios are unavailable (N/A) due to the company's net loss position, meaning traditional earnings-based valuation multiples cannot be applied to assess the expected earnings trajectory or investor expectations for future profitability. The price-to-book ratio is 0.30, indicating that the stock is trading at a significant discount to its book value, which often suggests the market undervalues the company's tangible assets or anticipates continued operational challenges. Alternative valuation metrics such as the price-to-sales ratio of 0.65 and an EV/EBITDA of 0.42 provide context, showing that the company trades at a fraction of its sales revenue and enterprise value relative to earnings before interest, taxes, depreciation, and amortization. The stock has a 52-week high of $12.18 and a 52-week low of $1.44, placing the current trading price within a wide volatility range that reflects high uncertainty regarding the company's future performance. The beta value is not available, so a precise assessment of the stock's price volatility relative to the broader market cannot be quantified based on the provided data, though the wide 52-week range itself suggests significant price fluctuations over the last year.
Growth & Income
Revenue growth year-over-year is -23.2%, while earnings growth is unavailable (N/A) due to the absence of net income, indicating that the company is currently shrinking in terms of top-line sales and has not yet demonstrated a path to profitable earnings expansion. The company does not pay a dividend, as the dividend yield is N/A and the payout ratio is 0.0%, meaning that any potential earnings are theoretically available for reinvestment rather than distribution to shareholders, although the current net loss limits the ability to fund organic growth internally. Because the firm is a non-dividend payer and operates at a loss, the primary mechanism for value creation relies entirely on future operational improvements rather than current income generation or shareholder payouts. The overall growth and income profile is defined by negative revenue expansion and a lack of current income distribution, presenting a scenario where the company must successfully execute a turnaround strategy to reverse the -23.2% revenue decline before it can generate sustainable earnings or consider initiating a dividend policy.